IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
33.19
+0.16 (0.48%)
At close: Mar 6, 2026, 4:00 PM EST
33.85
+0.66 (1.99%)
After-hours: Mar 6, 2026, 7:36 PM EST

IDEAYA Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
112.8384.38157.0268.6392.05
Short-Term Investments
526.56591.94368.1296.2154.72
Cash & Short-Term Investments
639.39676.32525.11364.83246.77
Cash Growth
-5.46%28.79%43.93%47.84%-12.98%
Accounts Receivable
--0.020.211.1
Other Current Assets
27.3413.397.55.413.12
Total Current Assets
666.73689.71532.63370.45251
Net Property, Plant & Equipment
31.2927.748.418.998.66
Long-Term Investments
410.3405.83107.498.32121.29
Other Long-Term Assets
1.020.810.780.210.4
Total Assets
1,1091,124649.32387.97381.35
Accounts Payable
17.5815.426.64.282.1
Accrued Expenses
40.8930.3518.761712.32
Current Portion of Leases
0.340.31.751.871.7
Unearned Revenue
---8.5729.04
Total Current Liabilities
58.8246.0727.131.7245.16
Long-Term Leases
27.5818.871.131.613.48
Other Long-Term Liabilities
---5.1931.19
Total Long-Term Liabilities
27.5818.871.136.834.67
Total Liabilities
86.3964.9428.2338.5179.83
Common Stock
0.010.010.010.010
Additional Paid-in Capital
1,7571,681968.89587.72478.97
Accumulated Other Comprehensive Income
2.270.810.56-2.87-0.71
Retained Earnings
-736.54-622.84-348.36-235.4-176.75
Shareholders' Equity
1,0231,059621.09349.46301.51
Total Liabilities & Equity
1,1091,124649.32387.97381.35
Total Debt
27.9119.172.873.485.18
Net Cash (Debt)
611.47657.15522.24361.35241.59
Net Cash Growth
-6.95%25.83%44.53%49.57%-12.74%
Net Cash Per Share
6.918.059.088.726.85
Book Value
1,0231,059621.09349.46301.51
Book Value Per Share
11.5612.9710.808.438.55
Tangible Book Value
1,0231,059621.09349.46301.51
Tangible Book Value Per Share
11.5612.9710.808.438.55
Updated Feb 17, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q